Halozyme Therapeutics (HALO) Prepaid Assets (2016 - 2025)
Historic Prepaid Assets for Halozyme Therapeutics (HALO) over the last 16 years, with Q3 2025 value amounting to $150.7 million.
- Halozyme Therapeutics' Prepaid Assets rose 2182.25% to $150.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $150.7 million, marking a year-over-year increase of 2182.25%. This contributed to the annual value of $119.5 million for FY2024, which is 7996.21% up from last year.
- Halozyme Therapeutics' Prepaid Assets amounted to $150.7 million in Q3 2025, which was up 2182.25% from $133.0 million recorded in Q2 2025.
- In the past 5 years, Halozyme Therapeutics' Prepaid Assets ranged from a high of $150.7 million in Q3 2025 and a low of $44.7 million during Q1 2021
- Moreover, its 5-year median value for Prepaid Assets was $67.6 million (2023), whereas its average is $80.4 million.
- Its Prepaid Assets has fluctuated over the past 5 years, first plummeted by 2028.99% in 2023, then skyrocketed by 8530.39% in 2024.
- Halozyme Therapeutics' Prepaid Assets (Quarter) stood at $53.9 million in 2021, then soared by 32.34% to $71.3 million in 2022, then dropped by 6.86% to $66.4 million in 2023, then skyrocketed by 79.96% to $119.5 million in 2024, then grew by 26.02% to $150.7 million in 2025.
- Its Prepaid Assets was $150.7 million in Q3 2025, compared to $133.0 million in Q2 2025 and $100.2 million in Q1 2025.